Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Biopharmaceutical company Scholar Rock Holding Corp (SRRK) recently announced that regarding the resubmission of its Biologics License Application (BLA), the company expects the U.S. Food and Drug Administration (FDA) to accept the filing within 30 days and initiate the formal review process.

Biopharmaceutical company Scholar Rock Holding Corp (SRRK) recently announced that regarding the resubmission of its Biologics License Application (BLA), the company expects the U.S. Food and Drug Administration (FDA) to accept the filing within 30 days and initiate the formal review process.

老虎证券老虎证券2026/03/31 11:16
Show original
The maximum review period is expected to last up to six months, starting from the date of resubmission. The company emphasized that this timeline is consistent with the FDA's standard procedures for handling BLA applications. If the review progresses smoothly, it will pave the way for the subsequent commercialization of related innovative therapies.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Signal of a rebound? Goldman Sachs US stock panic index reaches "extreme levels"

Goldman Sachs Volatility Panic Index surged to 9.57, approaching its maximum value, with the largest single-day increase ranking third in history, and the combined two-day volatility setting a new record. Historical data shows that after this index has exceeded the 9.5 threshold 15 times, the S&P 500 has seen an average three-month gain of 4.6% with a success rate of 80%. However, Goldman Sachs traders warn that forced liquidations have not yet fully cleared, and the market is still searching for a bottom, but opportunities on the other side are becoming increasingly difficult to ignore.

华尔街见闻•2026/11/07 07:31
Signal of a rebound? Goldman Sachs US stock panic index reaches "extreme levels"

SpaceX (SPCX.US) undergoes board changes: Google executive departs, Tesla merger evaluation underway.

SpaceX (SPCX.US) announced on Friday that Don Harrison has resigned from the company's board of directors.

智通财经•2026/11/07 06:31